These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
314 related items for PubMed ID: 20434203
1. What targeting eosinophils has taught us about their role in diseases. Bochner BS, Gleich GJ. J Allergy Clin Immunol; 2010 Jul; 126(1):16-25; quiz 26-7. PubMed ID: 20434203 [Abstract] [Full Text] [Related]
2. Anti-interleukin-5 therapy for asthma and hypereosinophilic syndrome. Kay AB, Klion AD. Immunol Allergy Clin North Am; 2004 Nov; 24(4):645-66, vii. PubMed ID: 15474864 [Abstract] [Full Text] [Related]
3. Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer. Amini-Vaughan ZJ, Martinez-Moczygemba M, Huston DP. Curr Allergy Asthma Rep; 2012 Oct; 12(5):402-12. PubMed ID: 22875242 [Abstract] [Full Text] [Related]
5. Role of vascular cell adhesion molecule-1 and platelet-activating factor in selective eosinophil migration across vascular endothelial cells. Sano H, Nakagawa N, Nakajima H, Yoshida S, Iwamoto I. Int Arch Allergy Immunol; 1995 Aug; 107(4):533-40. PubMed ID: 7542515 [Abstract] [Full Text] [Related]
6. Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions. Sedgwick JB, Jansen KJ, Kennedy JD, Kita H, Busse WW. J Allergy Clin Immunol; 2005 Oct; 116(4):812-9. PubMed ID: 16210055 [Abstract] [Full Text] [Related]
7. VCAM-1 is more effective than MAdCAM-1 in supporting eosinophil rolling under conditions of shear flow. Sriramarao P, DiScipio RG, Cobb RR, Cybulsky M, Stachnick G, Castaneda D, Elices M, Broide DH. Blood; 2000 Jan 15; 95(2):592-601. PubMed ID: 10627468 [Abstract] [Full Text] [Related]